Press Releases

Interpace Diagnostics Enters into Collaborative Agreement with Viatar CTC Solutions to Detect and Characterize Early Cancer in Liquid Biopsies

Feb 21, 2017

Interpace Diagnostics to Present at 2017 BIO CEO & Investor Conference

Feb 10, 2017

Interpace Diagnostics Announces Closing of $3.9 Million Public Offering

Feb 8, 2017

Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million

Feb 3, 2017

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Feb 2, 2017

Interpace Diagnostics to Present at NobleCon13

Jan 25, 2017

Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock

Jan 20, 2017

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jan 17, 2017

Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock

Jan 3, 2017

Interpace Diagnostics Group Announces 1-for-10 Reverse Split

Dec 28, 2016